Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostavasin (Prostaglandin E1) vs placebo in peripheral arterial occlusive disease Fontaine stage IV
2005-001970-29Phase 4Completed
- Sponsor
- Schwarz Pharma
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Vasostenoon in peripheral artery occlusion (PAD) (2 arms), sponsored by Schwarz Pharma. Started Sep 2005; status: completed.
02
Drugs
Vasostenoon
03
Conditions
peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on 2005-001970-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001970-29.